Clinical Trials Browser

Not yet recruiting × Colorectal Neoplasms × XELOX × Clear all

NCT07453875 2026-03-06

TRIUNITE06

Phase 1 Not yet recruiting

Gastrointestinal

Colorectal Neoplasms

NCT07229846 2026-01-08

A Single-arm, Single-center, Phase II Clinical Study of Aipalolitovorelizumab (QL1706) Combined With Bevacizumab and Standard Chemotherapy as First-line Treatment for MSS/pMMR Metastatic Colorectal Cancer With BRAF V600E Mutation

Phase 2 Not yet recruiting

Gastrointestinal

Colorectal Neoplasms